Back to R2 link
Top Industry News
- France ANSM - Clinical Drug Trials: All Transition Requests Must be Submitted on the CTIS Portal
- MHRA Apply for a Licence to Market a Medicine in the UK
- ANVISA Publishes New Edition of the Biosurveillance Manual
- ANVISA Receives Contributions to Review the SNVS Organizational Guidelines
- SAHPRA Signs MoU With Medicines Control Authority Of Zimbabwe
- The China Fragrance, Flavor, and Cosmetics Industry Association released three group standards, including the standard for "Hexapeptide-11 as Cosmetic Raw Material
- HSE Final Opinions on 90 Substances for Mandatory Classification under GB CLP (Contains Titanium Dioxide)
- Health Canada’s Notification of Amendment to the List of Approved Supplemental Ingredients, Allowing the Inclusion of Green Tea Extract (EGCG/catechins) in Foods as a Supplemental Ingredient
- TGA Announces Repeal of Therapeutic Goods (Restricted and Prohibited Representations—Nicotine) Permission (No. 2) 2021
- EFSA Releases Findings Confirming Health Concerns Regarding Inorganic Arsenic in Food
- MHRA Medical Devices: UK Approved Bodies